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A B S T R A C T
Prostaglandin E2 (PGE2) is an important lipid mediator that plays diverse functions in mammals. Four
receptor subtypes of PGE2, designated EP1-4, have been identiﬁed to mediate its signaling pathways.
Extensive studies of PGE2 and its receptors have been carried out in mammals, but little is known in
ﬁsh, including Atlantic salmon. In the current study, the distribution of Atlantic salmon EP4 receptor in
different tissues was investigated using RT- and real-time PCR. A custom made antibody was used to in-
vestigate the distribution of this receptor in different tissues. Quantitative analysis by real-time PCR revealed
that the expression was more abundant in the spleen followed by head kidney, skin and ﬁn while it was
least expressed in heart, muscles and brain. The staining intensity obtained by immunohistochemistry
correlated with the RT-PCR results. EP4 expression was strongly associated with the immune cells in dif-
ferent tissues. To our knowledge, this is the ﬁrst study to describe the distribution of EP4 receptor in
Atlantic salmon tissues. Our ﬁndings suggest that EP4 may play a role in mediating immune responses
as observed in mammals.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Prostaglandins (PGs) are lipid mediators that are produced by
nearly all cells in the body. They are synthesized from arachidonic
acid by the cyclooxygenase (COX) enzymes (Smith, 1992). Among
different types of PGs, PGE2 is the most abundant with diverse func-
tions such as maintaining homeostasis, pro- and anti-inﬂammatory
functions (Frolov et al., 2013; Nakanishi and Rosenberg, 2013; Yao
et al., 2009).
PGE2 exerts its functions by binding to different receptors. Four
different subtypes of PGE2 receptors are found in mammals and are
designated as EP1-4. These are G-protein coupled receptors that
belong to a family of seven rhodopsin-like transmembrane span-
ning receptors. They are structurally different and share less than
35% sequence identity within one species (Sugimoto et al., 1993).
EP1 and EP4 have relatively long third intracellular loops com-
pared to EP2 and EP3. EP4 is characterized by its long intracellular
domain while EP3 is distinguished by the presence of multiple
isoforms (Sugimoto et al., 1993). The expression and distribution
of these receptors vary between different tissues and cell types
(Fennekohl et al., 1999; Sugimoto and Narumiya, 2007). Function-
al differences in the signaling cascade mediated by these receptors
have also been reported. In general, EP2 and EP4 are considered as
stimulatory receptors. They induce signaling cascade that leads to
increased levels of cyclic adenosine monophosphate (cAMP) (Fujino
et al., 2005). In contrast, EP3 is considered as inhibitory receptor
and leads to decreased cAMP concentration (Fabre et al., 2001). Sig-
naling through EP1 receptor, on the other hand, leads to increased
intracellular calcium concentration (Katoh et al., 1995).
The heterogeneity in PGE2 induced effects can partially be ex-
plained by the presence of multiple receptors. For example,
stimulation of gastric acid secretion and smooth muscle relax-
ation in themurine gastrointestinal tract were shown to bemediated
by EP4 whereas an opposite effect was mediated by EP3 (Ding et al.,
1997; Okada et al., 2000). In mixed lymphocyte response, EP2 and
to a lesser extent EP4 were found to be responsible for the inhib-
itory effect induced by PGE2 while the involvement of EP1 and EP3
was ruled out (Nataraj et al., 2001). Differences in PGE2 induced effect
on the development of colorectal cancer can also be attributed to
the receptor diversity (Hull et al., 2004). It is noteworthy, however,
that the functions mediated by the different receptors are not always
conserved and can vary between different species (Larsen et al., 2005;
Takeuchi et al., 1999).
Knowledge about EP receptors in ﬁsh is still developing. EP re-
ceptors of the zebraﬁsh are the best studied among ﬁsh species
and have only been characterized recently. All the four different EP
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subtypes are present in zebraﬁsh and two isoforms of EP2, three
of EP1 and EP4, and ﬁve of EP3 were characterized (Iwasaki et al.,
2013; Kwok et al., 2012; Tsuge et al., 2013). Analysis of the differ-
ent zebraﬁsh EP amino acid sequences revealed 40–70% sequence
identity to their human counterparts. In all subtypes, the seven trans-
membrane regions are conserved and most of the differences are
in the extra and intracellular loops (Iwasaki et al., 2013; Kwok et al.,
2012; Tsuge et al., 2013). However, the distribution of these recep-
tors or their functions in different tissues has not yet been studied
in detail. For Atlantic salmon, EP4 is the only subtype that has been
identiﬁed so far (Leong et al., 2010). Although the genomic se-
quence of Atlantic salmon EP4 (asEP4) and its corresponding amino
acid are deposited in the GenBank, there is no record of any study
that has been conducted to understand its functional aspects. The
aim of the present study was to investigate the distribution of asEP4
receptor in different tissues by PCR and immunohistochemistry.
2. Materials and methods
2.1. Fish and sampling
Atlantic salmon pre-smolts were obtained from Sør-Smolt AS and
kept at the wet lab facility of the Norwegian University of Life Sci-
ences (Adamstuen campus) at about 10–12 °C and fed with
commercial dry pellets. At the time of sampling, ﬁsh were anes-
thetized by an overdose of benzocaine and sacriﬁced in accordance
with the regulation of the Norwegian Directorate of Fisheries and
different tissues were sampled and placed in RNA later (Sigma
Aldrich) for RNA extraction.
2.2. Tissue specimens
Paraﬃn embedded tissue sections obtained from normal tissues
were retrieved from the archives of the section of Aquatic Medi-
cine, Department of basic science and Aquatic Medicine of the
Norwegian University of Life sciences. For each tissue, three or more
sections were used for immunohistochemical examination.
2.3. Cell culture
Epithelioma papulosum cyprini (EPC) cells (Fijan et al., 1983) were
maintained at 20 °C in L-15 glutamax media (Invitrogen, Carlsbad,
CA, USA) supplemented with 10% FBS.
2.4. RNA isolation and cDNA synthesis
RNA was isolated from different Atlantic salmon tissues namely
heart, spleen, gills, head kidney, brain, intestine, kidney, muscle, liver,
ﬁn and skin. Approximately 30 mg of tissues were placed to
Eppendorf tubes containing 1 ml ISol-RNA Lysis Reagent (5Prime,
Gaithersburg, MD, USA). Tissues were then homogenized in
Mixer Mill MM301 homogenizer (Retsch, Haan, Germany) using
stainless steel beads at 20 Hz until well homogenized. After ho-
mogenization, samples were subjected to phase separation by adding
0.2 ml chloroform. The aqueous phase was passed through gDNA
column removing genomic DNA followed by RNA isolation using
RNeasy Plus mini kit (Qiagen, Hilden, Germany) following the ma-
nufacturer’s instructions. The obtained RNA concentration was
determined by spectrophotometry using a Nanodrop ND1000
(Thermo Scientiﬁc, Pittsburgh, PA, USA).
Following RNA isolation, 1 μg RNA obtained from each tissue was
used for cDNA synthesis by Transcriptor First Strand cDNA Synthe-
sis Kit (Roche, Mannheim, Germany) using both oligo (dT) and
random hexamer primers, following the manufacturer’s protocol.
2.5. Ampliﬁcation of the full length EP4 receptor
The cDNA obtained from different tissues was diluted 1:5 and
4 μl of each was used for PCR ampliﬁcation (40 cycles) using
Accustart Taq DNA Polymerase HiFi (Quanta Bioscience, Gaithersburg,
MD, USA) and 5 pmol forward and reverse primers (Table 1). The
cycling conditions were as follow: 94 °C for 30 s, 60 °C for 1 min,
68 °C for 2.5 min.
2.6. Real time PCR
In order to quantify the expression of EP4 in different tissues,
cDNA was synthesized from 500 ng total RNA obtained from dif-
ferent tissues of seven different ﬁsh, as described earlier. Real-
time PCR was performed in 96-well plates using the LightCycler 480
system (Roche). Each reaction containing 2μl cDNA was mixed with
10 pmol gene speciﬁc primers (Table 1) and 10 μl LightCycler 480
SYBR green I master mix (Roche). The ﬁnal volume was adjusted
to 20 μl using RNase free water. The primers were validated by: (1)
melting curve analysis; (2) presence of a single band when the PCR
products were electrophoresed in agarose gel; and (3) representa-
tive PCR products from tissues with high and low EP4 expressions
were sequenced by GATC biotech. The cycling (40 cycles) condi-
tions for the PCR reactions were as follows: 94 °C for 10 s; 60 °C for
20 s; 72 °C for 10 s. The relative expression in each tissue was cal-
culated by dividing the 2Cp value obtained for β-actin over those
obtained for EP4 followed by normalization to a calibrator as pre-
viously described (Pfaﬃ, 2004).
2.7. Generation and validation of asEP4 antibodies
To examine the distribution of EP4 proteins in different Atlan-
tic salmon tissues, a custom made polyclonal antiserum
was used. The antibodies were produced commercially by
Proteogenix (Oberhausbergen, France) in a rabbit using the cys-
QDQQTQAGKGMQKDPKKGPR peptide. To validate the antibodies, the
full length EP4 ampliﬁed from skin were cloned into pCR2.1 vector
using the TOPO TA cloning Kit (Invitrogen) following manufactu-
rer’s instructions. The coding sequence was then ampliﬁed using
the primers with XhoI and SalI restriction sites (Table 1) and sub-
sequently cloned into pMAX-FP-GreenC vector (Lonza, Basel,
Table 1
Primers used in the study.
Name Sequence Used for Accession no
FL-EP4-For
FL-EP4-Rev
5′-ACAAAAACACTTCGGATAGTCAAAAACC-3′
5′-GGGACAAAGTTCACATTGTAGCC-3′
PCR/TA cloning NM_001173955.1
As-EP4-For
As-EP4-Rev
5′-GGTTGAACTGAAATACACG -3′
5′-CTGCTAGACTGACATTCC-3′
Real-time PCR NM_001173955.1
Β-actin-For
Β-actin-Rev
5′- CCAGTCCTGCTCACTGAGGC-3′
5′- GGTCTCAAACATGATCTGGGTCA -3′
Real-time PCR AF012125
XhoI-EP4-For
SalI-EP4-Rev
5′- ACGCCTCGAGCTTCGGGTATGAATAAC-3′
5′- ACGCGTCGACTTAGATGCATTTCTCCTG-3′
Cloning
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Switzerland) in order to be expressed fused to GFP (GFP-EP4).
After cloning plasmids were veriﬁed by sequencing using GATC
biotech.
A total of 1 × 106 EPC cells were transfected with 5 μg of either
pMAX-FP-GreenC vector or with GFP-EP4 plasmids. Transfection was
performed by electroporation using Neon transfection system
(Invitrogen, Carlsbad, CA, USA) with one pulse of 1200 V for 40 ms.
After transfection, cells were seeded into 24-well plates and kept
for 48 h before being stained by the custom made anti EP4 anti-
bodies using indirect ﬂuorescence antibody test (IFAT). Cells were
ﬁxed using 4% paraformaldehyde for 10min and then permeabilized
using 0.1 Triton-x100 for 5 min on ice. The custom made anti EP4
(1:1000) was added for 1 h at room temperature. Alexa Fluor 594
goat anti rabbit IgG (Invitrogen, Carlsbad, CA, USA) was added at
1:400 dilution and incubated at room temperature for 45min. Cells
were counterstained with Hoechst (5 μg/ml) before being exam-
ined under a ﬂuorescence microscope.
2.8. Immunohistochemstry
After deparaﬁnization and dehydration, sections of 4 μm thick-
ness mounted onto poly-l-lysine-coated slides were blocked for 2
h with 5% bovine serum albumin (BSA) in 0.05 M Tris buffer saline
(TBS) pH 7.6. Slides were then incubated with anti EP4 antibodies
diluted 1:1000 in 2.5% BSA overnight at 4 °C. After washing in TBS
plus 0.025% Triton-x100 (TBST), slides were incubated in biotinylated
secondary anti rabbit antibody (Dako, Glostrup, Denmark) diluted
1:300 in 2.5% BSA for about 1 h at room temperature. The slides
were thenwashed again and streptavidin–alkaline phosphatase con-
jugate (GE healthcare, Piscataway, NJ, USA) diluted 1:100 in 2.5%
BSA was added for 30 min. The signal was developed by adding
fast red substrate (Sigma Aldrich, St. Louis, USA) according to
the protocol described by the manufacturer. The reaction was
stopped after 2–3 min by washing in tap water and the slides were
counterstained with Mayer’s hematoxylin for 3 min and ﬁnally
mounted in Aquatex (Merck, Darmstadt, Germany), before visual-
ization under the microscope. For some of the tissues where signal
saturation was observed, the primary antibody dilution was ad-
justed to 1:3000.
3. Results
3.1. Distribution of EP4 receptors in Atlantic salmon tissues by PCR
EP4 receptors were detected by RT-PCR in all investigated tissues
except the brain (Fig. 1a). However, by real-time PCR low expres-
sion level (Cp ≤ 35) was detectable in the brain from two ﬁsh (data
not shown). The expression levels in different tissues were also quan-
tiﬁed by real-time PCR (Fig. 1b). Themost abundant expressions were
found in the spleen followed by the head kidney, ﬁn and skin. Rel-
atively moderate levels of expression were found in the liver and
gills and to a lesser extent in the intestine. The weakest expres-
sion was found in the heart and muscles.
3.2. Validation of anti-asEP4 antibodies
The validity of the anti-asEP4 antibodies was documented by
strong, red coloration in EPC cells transfected with EP4-GFP ex-
pressing plasmid (Fig 2a; red channel). Co-localization with GFP
signal was shown (Fig. 2b; green channel). Themerged picture docu-
ments the co-localization in the same cell (Fig. 2d). The speciﬁcity
of the antibodies was further shown by lack of staining EP4 signal
in the empty plasmid (expressing only GFP; Fig. 2e, f, h). Cell nuclei
are visualized by Hoechst counterstain (Fig. 2c and g).
3.3. Distribution of EP4 proteins within different Atlantic
salmon tissues
In general the intensity of staining observed by immunohisto-
chemistry correlated with the expression pattern by RT-PCR except
for the heart and muscles where no expression was detected. The
expressions in individual tissues were as follows.
3.3.1. Fin and skin
The expression of EP4 in the skin was only found in the epider-
mis. Different patterns of expression were observed between the
sections obtained from three different ﬁsh. In two of them the ex-
pression was found to be intense toward the surface and less intense
in the intra epidermal cells (Fig. 3a and c). In contrast, in the third
ﬁsh, intense expression was seen in the cytoplasm of intraepidermal
cells (Fig. 3b and d). A similar pattern of expression was found in
dorsal ﬁns obtained from the same individuals (Fig. 3e–h).
3.3.2. Gills
The expression of EP4 was mainly limited to the epithelial lining
of the gill ﬁlaments (Fig. 4a). In some areas, an intense staining was
found at the base of the ﬁlament (Fig. 4b).
3.3.3. Intestine and pyloric caeca
In the pyloric caeca, EP4 expression was found in the lamina
propria and the intraepithelial leukocytes while no expression was
detected in the epithelial cells (Fig. 5a). Positive staining was also
observed in the rodlet cells. In the individual cells, the expression
was either localized to the cell membrane or diffused in the cyto-
plasm of the cells (Fig. 5b).
A
B
Fig. 1. The expression of asEP4 receptor in different tissues by PCR. (a) One micro-
gram total RNA isolated from the indicated tissues was used to perform RT-PCR (as
described in Section 2.4). (b) Real-time PCR was performed on cDNA obtained from
seven individuals and the results were calculated by relative expression and nor-
malized to calibrator as described in Section 2.5. Bars show the normalized
values ± S.E.M.
145A.A.A. Gamil et al./Developmental and Comparative Immunology 48 (2015) 143–150
3.3.4. Head kidney and spleen
In the head kidney, EP4 was diffusely expressed in the
hematopoeitic tissue (Fig. 6a and b) while in the spleen it was found
mainly in the white pulp (Fig. 6c and d). Interestingly, intense stain-
ing was found in the cytoplasm of the splenic melanomacrophages
(Fig. 6e and f, details).
3.3.5. Liver
The expression in the liver was mainly associated with the bile
ducts and somemonocyte-like cells in the hepatic parenchymawhile
no expression was found in the hepatocytes (Fig. 7).
4. Discussion
In the present study we have investigated the expression of EP4
receptor in different Atlantic salmon tissues by RT-PCR and immu-
nohistochemistry. To our knowledge, this is the ﬁrst study to report
the expression of EP4 receptor in Atlantic salmon tissues. The se-
quence of asEP4 has been published earlier but with no focus on
receptor expression at mRNA or protein level (Leong et al., 2010).
With an attempt to compare our ﬁndings to other species, we were
not able to ﬁnd other studies that have investigated the global EP4
expression in different tissues by immunohistochemistry al-
though studies that focused on individual tissues are present.
The mRNA expression of asEP4 studied by RT-PCR shows that
EP4 is expressed in many different tissues in Atlantic salmon which
is comparable to other species (Sugimoto and Narumiya, 2007) al-
though some distinct differences are present. For example, in mice
the expression of EP4 receptor was found to be more abundant in
the thymus, part of the digestive (ileum) and reproductive (uterus)
organs while it was least abundant in spleen and kidney (Sugimoto
and Narumiya, 2007). However, in this study we found that it is
strongly expressed in the immune organs (spleen and head kidney).
The difference in tissue expression suggests that differences in func-
tionality may also exist. Direct comparison between zebraﬁsh and
asEP4 is diﬃcult due to the lack of quantitative expression data and
the presence of multiple isoforms in zebraﬁsh compared to only one
identiﬁed so far in Atlantic salmon. It is however not unlikely that
Atlantic salmon has other isoforms that are yet to be identiﬁed.
Among the three identiﬁed zebraﬁsh EP4 receptors, EP4b has a
similar wide tissue distribution as asEP4 while the other two are
exclusively expressed in few tissues (Tsuge et al., 2013). One of the
main differences between the expression patterns of zebraﬁsh EP4b
and asEP4 is that zebraﬁsh EP4b mRNA was found to be expressed
in the brain but could not be detected in the heart by PCR while
the opposite was found for asEP4. Another observation was that the
level of expression observed by RT-PCR correlated with the inten-
sity of staining observed by immunohistochemistry. The only
exception was heart and muscle where no expression was de-
tected by immunohistochemistry. This might be due to differences
in detection limit between the two methods or simply due to im-
purities in the templates used for RT-PCR.
In mammals, PGE2 is known to modulate the functions of dif-
ferent populations of immune cells (Harizi et al., 2003; Ikegami et al.,
2001; Luschnig-Schratl et al., 2011;Minakuchi et al., 1990). The im-
portance of EP4 inmediating these responses has been investigated.
Using RT-PCR and western blot, it was shown that EP4 is expressed
byB cells, T cells, eosinophils, dendritic cells andmacrophages (Harizi
et al., 2003; Ikegami et al., 2001; Mita et al., 2002; Nataraj et al.,
2001). It was further shown that EP4mediates the inhibitory effect
induced by PGE2 on cytokine production by macrophages (Nataraj
et al., 2001). In the present study, asEP4 was found to be strongly
expressed in the spleen and head kidney by RT-PCR. Using immu-
nohistochemistry, asEP4 was found expressed in leukocytic cells in
both organs, and interestingly, strongly associated with the splenic
melanomacrophages.Moreover, itwas also found in livermonocyte-
like cells and in the intra-epithelial leukocytespresent in the intestine.
These ﬁndings suggest that asEP4might play a role in local immune
functions as demonstrated in mammals. Further studies are re-
quired, however, to demonstrate this.
Expression of the EP4 receptor in Atlantic salmon liver was limited
to the bile ducts and intrahepatic monocytes-like cells. In rat liver,
Fig. 2. Validation of anti-EP4 antibodies. The coding sequence was cloned into pMAX-FP-GreenC vector (Lonza, Basel, Switzerland) and overexpressed in EPC cells. (a) Stain-
ing (red) with anti-asEP4 antibodies, (b) GFP-expression, (c) Hoechst nuclear staining, (d) merge of (a)–(c), (e) pMAX-FP-GreenC vector plasmid (no-EP4 sequence), (f) GFP-
expression empty vector, (g) Hoechst staining, (h) merge of (e)–(g).
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the expression of EP4 mRNA was detected strongly in the endo-
thelial cells while weak or no expression was detected in Kupffer
and liver stellate cells (Fennekohl et al., 1999). However, we did not
ﬁnd any study that describes the expression of EP4 receptor in
hepatic tissues by immunohistochemistry in other species. While
the expression of EP4 in the immune cells is well documented, the
expression in the bile ducts has not been previously reported al-
though EP4mRNA expressionwas detected in gall bladder carcinoma
Fig. 3. Expression of EP4 receptor in Atlantic salmon skin and ﬁn. Skin (A–D) and ﬁn (E–H) tissue sections were stained with anti-asEP4 polyclonal antibodies dilutes 1:1000
(b, d, f, h) or 1:3000 (a, c, e, g). The expression is detected only in the epidermis and is either localized to the surface (a, c, e, g) or to individual intra epidermal cells (b, d,
f, h). Original magniﬁcations are 200× (a and b, e–f) and 400× (c–d, g–h).
Fig. 4. Expression of EP4 receptor in Atlantic salmon gill. Gill tissue sections were stained with anti-asEP4 polyclonal antibodies dilutes 1:1000 (a) or 1:3000 (b). The ex-
pression is exclusively detected only in the epithelial lining of the gill ﬁlaments. Original magniﬁcations are 100× (a) and 200× (b).
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(Asano et al., 2002). It is known that PGE2 plays an important
role in protecting the epithelial lining of the gallbladder
from the bile salts by stimulating the secretion of mucin in
a cAMP dependent manner (Behar, 2013; Kuver et al., 1994).
The expression of asEP4 in the epithelium of the bile ducts
suggests that it may play a role in maintaining the integrity
of the bile duct epithelium. Other roles cannot be excluded
given that EP2 has been suggested to play a novel role in PGE2
Fig. 5. Expression of EP4 receptor in Atlantic salmon pyloric caeca. Sections were stained with anti-asEP4 polyclonal antibodies dilutes 1:1000. The expression is detected
in the lamina propria and the intra epithelial leukocytes as well as the rodlet cells. Original magniﬁcations are 200× (a) and 400× (b).
Fig. 6. Expression of EP4 receptor in Atlantic salmon head kidney and spleen. Head kidney (a and b) and spleen (c–f) tissue sections were stained with anti-asEP4 polyclonal
antibodies dilutes 1:1000. The receptor is diffusely expressed in the head kidney hematopoietic tissue while in the spleen it is mainly expressed in the white bulb. Note the
strong association between the receptor and the melanomacrophage in the spleen (e and f). Original magniﬁcations are 200× (a and c), 400× (b, d, e) and 630× (f).
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mediated regulation of glucose metabolism in other ﬁsh species
(Busby et al., 2002).
EP4 receptor is known to mediate the protective effect of PGE2
on the respiratory, gastrointestinal and glomerular epithelial lining
(Aoudjit et al., 2006; Kabashima et al., 2002; Schmidt et al., 2011).
In this study, the expression of asEP4 in the gills was limited to the
epithelial lining suggesting that the EP4 receptor may mediate a
similar protective role. In contrast, the expression in the pyloric caeca
was limited to the intraepithelial leukocytes and no expression was
detected in the epithelium. Our results are in agreement with the
ﬁnding of Hult et al. who found that the expression of EP4 protein
in human intestine is limited to the lamina propria and the intes-
tinal crypts (Hult et al., 2011). In humans andmice, different patterns
of expression are seen across the gastrointestinal tract (Lejeune et al.,
2010; Morimoto et al., 1997). Hence, the presence of EP4 in other
parts of the gastrointestinal tract in Atlantic salmon should be further
investigated.
The expression of EP4 receptor in the skin has previously been
investigated in mice (Lee et al., 2005; Tober et al., 2007). While it
is well established that the EP4 receptor can be detected by RT-
PCR (Lee et al., 2005; Rundhaug et al., 2011), contradictory ﬁndings
have been reported regarding the expression of EP4 proteins by im-
munohistochemistry. One study reported that EP4 is undetectable
(Lee et al., 2005) while another one showed that it can be de-
tected in skin epidermal keratinocytes and dermal leukocytes (Tober
et al., 2007). In the current study, asEP4 expression was detected
in Atlantic salmon skin both by RT-PCR and immunohistochemis-
try. The expression of asEP4 proteins was found to be exclusive to
the epidermis in the examined ﬁsh but with different levels and pat-
terns. The reason behind different levels and patterns of expression
observed remains unclear. It was reported previously that the ex-
pression of EP4 receptor in the colon and other EP receptors in the
skin becomemore intense and diffused when it is inﬂamed or upon
exposure to chronic radiation respectively (Lee et al., 2005; Lejeune
et al., 2010). Since intense and diffuse staining of somemitotic ﬁgures
and lymphocytes in some areas in skins were present, one possi-
ble explanation is that the different patterns of expression observed
are due to some ongoing inﬂammatory process although normal
physiological differences cannot be excluded.
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